Tag: <span>Drugs</span>

Home / Drugs
Computer algorithms find tumors’ molecular weak spots
Post

Computer algorithms find tumors’ molecular weak spots

By Roxanne KhamsiJun. 11, 2020 , 2:00 PM In 2016, doctors invited Eileen Kapotes to join a clinical trial for a drug that had never been used for her disease. Kapotes, a first grade teacher in her 50s, was fighting an aggressive breast cancer that had spread through her body. She had endured grueling treatments...

Solubilizer Captisol enables body to absorb authorized COVID-19 drug therapy
Post

Solubilizer Captisol enables body to absorb authorized COVID-19 drug therapy

RENDERING OF THE MOLECULAR STRUCTURE OF CAPTISOL, THE SOLUBILIZER INVENTED AT THE UNIVERSITY OF KANSAS, WHICH ALLOWS REMDESIVIR TO BE ADMINISTERED TO THE PATIENT. REMDESIVIR WAS RECENTLY AUTHORIZED UNDER AN… view more CREDIT: VALENTINO STELLA, UNIVERSITY DISTINGUISHED PROFESSOR EMERITUS AT KU LAWRENCE — When the Food and Drug Administration issued an emergency-use authorization for the...

COVID-19 study good news for rheumatic disease patients on immunosuppressants
Post

COVID-19 study good news for rheumatic disease patients on immunosuppressants

A European League Against Rheumatism (EULAR) database containing information on the effects of COVID-19 on patients with rheumatic and musculoskeletal diseases has given some reassurance to patients taking immunosuppressants. The drugs studied by the team include anti-malarial drugs, methotrexate, biological therapies such as TNF-alpha inhibitors, and nonsteroidal anti-inflammatory drugs such as Naproxen. None of them...

Post

Romosozumab in osteoporosis: Considerable added benefit for women after menopause

Fewer vertebral fractures and fewer other typical fractures in postmenopausal women with severe osteoporosis at high risk of fracture INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE Romosozumab is a bone-forming monoclonal antibody used in women after menopause for the treatment of severe osteoporosis if there is a high risk of bone fractures. Having been...

Improved gut microbiota with cholesterol-lowering medication
Post

Improved gut microbiota with cholesterol-lowering medication

by Margareta Gustafsson Kubista, University of Gothenburg There is a clear link between improved gut microbiota and one of our most common cholesterol-lowering drug groups: statins. This is evident from a European study involving researchers from the University of Gothenburg. Scientists have previously found an association between the gut microbiota and various metabolism-related and cardiovascular...

Blood cancer find raises new treatment hopes
Post

Blood cancer find raises new treatment hopes

by QIMR Berghofer Medical Research Institute New QIMR Berghofer research has identified how an early genetic change in blood and bone marrow cells paves the way for the development of some blood cancers. The discovery provides a new target for treatment of the blood cancers myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). MDS is...

Antidepressant fluoxetine (Prozac) suppresses replication of SARS-CoV-2
Post

Antidepressant fluoxetine (Prozac) suppresses replication of SARS-CoV-2

By Sally Robertson, B.Sc A study conducted by researchers at Julius-Maximilians-Universität Würzburg has shown that the antidepressant agent fluoxetine may be an effective drug for the early treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among at-risk groups. Jochen Bodem and colleagues found that the selective serotonin reuptake inhibitor (SSRI) fluoxetine significantly inhibited viral...

Existing drugs may limit damage caused by HIV
Post

Existing drugs may limit damage caused by HIV

by Yale University Yale researchers have identified four drugs that may help minimize the long-term health effects of HIV infection, they report June 23 in the Journal of Clinical Investigation. Antiretroviral therapy has proved to be a life-saving treatment for those infected with HIV. Yet even after treatment, most patients still harbor latent HIV in...